GLP-1s tied to 37% higher hair loss risk, study finds

Mackenzie Bean / beckershospitalreview - GLP-1 receptor agonists carry a higher risk of hair loss than other diabetes medications, according to a study published July 22 in The BMJ. Researchers at Philadelphia-based Penn Medicine used EHR data to compare adults with Type 2 diabetes who started G…

AI Summary: A series of new analyses tie GLP‑1 diabetes and obesity drugs to a measurable rise in hair loss reports, with varying risk estimates prompting doctors to warn patients and researchers to dig deeper. Clinicians urge monitoring and clearer guidance as these widely used medications shift from metabolic miracles to potential cosmetic headaches.